A telephone call was held between His Royal Highness Prince Salman bin Hamad Al Khalifa, Crown Prince and Prime Minister and Vertex Pharmaceuticals CEO and President Dr Reshma Kewalramani yesterday.
HRH Prince Salman highlighted the kingdom’s medical milestone in successfully completing the treatment of the world’s first sickle cell disease patient outside the United States with Casgevy (exagamglogene autotemcel), a CRISPR-based gene-editing therapy using bone marrow transplantation technology .
&uuid=(email))